Patients were asked about the diagnosis criteria of the International RLS study group and their laboratory examinations along with 25 (OH) D vitamin levels were assessed. Results: Seventy-five patients, 40 of whom were female, were included in the study. The average age of patients was 57.8 (19-84). Average 25 (OH) vitamin D levels of 75 patients in total were found to be 12.6 ±6.27 (3-30). Five patients had 25 (OH) D vitamin insufficiency and 70 had 25 (OH) D vitamin deficiency. Thirty-three patients were diagnosed with RLS and their average vitamin D levels were 10.76 ±4.56; the D levels of 42 patients not diagnosed with RLS were found to be 14.18±7.02. A significant relationship was determined between the patients diagnosed with RLS and their vitamin D levels (p=0.018).
Introduction
Restless legs syndrome (RLS) is a condition characterized by an uncomfortable sensation, pain and cramp in legs, involuntary leg movements and related sleep disorders which occur especially during sleep at night [1] . Having increasing and more apparent symptoms during resting at night is typical. RLS is diagnosed through the urge to move extremities along with paresthesia or dysesthesia sensations, increasing symptoms during resting and decreasing symptoms during moving, inability to stand still (walking, shaking, contraction, and rubbing) and aggravating symptoms at night. The frequency of RLS is around 5-15% in the general population [2] . Recently, RLS is commonly seen due to end-stage renal failure. Its prevalence has a wide distribution range of 6.6% and 70% among dialysis patients, and it is significantly higher than the rates seen in the general population [1, [3] [4] . Vitamin D metabolism disorders are commonly seen in chronic kidney diseases (CKD). Vitamin D synthesis is related to the failure of turning 25 [5] . In conducted studies, CKD is indicated as the secondary reason of RLS. However, its etiology is not exactly known. RLS is more commonly encountered in CKD compared to the general population. The purpose of this study was to reveal the relationship between vitamin D level and RLS on the basis of the fact that vitamin D deficiency is frequent in CKD.
Materials and Method
Seventy-five hemodialysis patients who applied to our outpatient clinic and received hemodialysis treatment in our center between March 2012 and May 2012 were included in the study. Chronic renal failure patients who were older than 18 years of age and were receiving hemodialysis treatment at least for three months were included in the study. Patients diagnosed with a peripheral arterial disease, hemiplegia and mentally retarded patients were excluded from the study. Blood samples of patients were analyzed for their 25 (OH) vitamin D, serum iron, iron binding capacity, ferritin, calcium, phosphorus, parathyroid hormone, and complete blood counts before hemodialysis. Diagnosis criteria specified by the International RLS study group and shown in Table 1 were used for diagnosing of RLS. Diagnosis of RLS has required all diagnosis criteria to be positive.
Statistical analysis
The data obtained from our study were evaluated by using SPSS 14.0 program. Two independent t tests were used when parametric test assumptions were performed, and Mann Whitney U test and Chi-square test were used when non-parametric test assumptions were performed, and level of significance was accepted as 0.05.
Results
A total of 75 patients were included in the study, the average age of patients was 57.8 (19- had vitamin D levels of < 10 ng/ml. Tables 2 and 3 illustrate demographic and laboratory data of patients. Table 1 . International RLS study group's diagnosis criteria
1. An urge to move the legs, usually accompanied or caused by uncomfortable and unpleasant sensations in the legs 2. The urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity such as lying or sitting 3. The urge to move or unpleasant sensations are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues 4. The urge to move or unpleasant sensations are worse in the evening or night than during the day or only occur in the evening or night [1] . RLS is the apparent sensation of discomfort in lower extremities which increase generally at night when complaints are on the rise, with an urge to move legs and decrease when legs are moved. It may be associated with idiopathic, hereditary (primary RLS) or other clinical conditions, and may have secondary reasons such as iron deficiency, end-stage renal failure, pregnancy, rheumatic diseases, and diabetes mellitus. Also, it may also be encountered in neurological conditions (Parkinson, spinal cord lesions, multiple sclerosis, polyneuropathy) [6] . RLS was defined by Callghan for the first time in 20 chronic renal failure patients [7] . In a study conducted by Rogers et al., in 1991, the frequency of RLS was 40% in 55 patients (34 hemodialyses and 21 peritoneal dialyzes) [8] . In a study conducted by Çölbay et al., in Turkey, the frequency of RLS in hemodialysis patients was 43.3% [9] . The fact that RLS symptoms responded to dopamine agonists and levodopa has been considered as proof that dopaminergic dysfunction plays a role in RLS pathophysiology [10] . Additionally, metoclopramide which is a dopamine antagonist showed that pimozide increased RLS symptoms [11] [12] . It is remarkable that RLS symptoms increase at night when dopamine levels are the lowest and decrease in morning hours when dopamine levels are higher, in compliance with dopamine circadian rhythm. Dopaminergic agents are used for primary RLS treatment; however etiology-focused treatments are preferred for secondary RLS (pregnancy, end stage renal failure and anemia) [13] . Parkinson's disease is characterized by the loss of dopaminergic cells gradually in the nigrostriatal pathway. Early findings of Parkinson's disease were observed in case of bradykinesia, walking disorders, rigidity, and the loss of tremor strial dopamine at a rate of 80-90% and nigral dopaminergic neurons at a rate of 50% [14] [15] [16] [17] . In a cohort study conducted by Knekt et al., in Finland, they examined the relationship between vitamin D levels and risk of Parkinson's disease and as a result of 29-year follow-up of 3713 individuals above the age of 50, they found out that the individuals, who had low vitamin D levels, in the beginning, had higher risk of Parkinson's disease [18] . In a study conducted by Evatt et al., with Parkinson's and Alzheimer's disease patients, they found out that the vitamin D deficiency prevalence of Parkinson's disease patients was higher compared to Alzheimer's and control groups. Researchers reported that the vitamin D insufficiency in Parkinson's disease patients was 55% whereas vitamin D deficiency was 23% [19] . In a recently conducted study, the presence of vitamin D receptor was proved in the dopaminergic neurons in human and rat brains. Due to the nuclear location of vitamin D receptors, it is asserted that vitamin D could affect cell proliferation, differentiation and even life cycles in these neurons. These results support the relationship of abnormal dopaminergic transmission diseases such as schizophrenia and Parkinson's disease with vitamin D [20] . It was reported in an in-vitro study that the increasing intense expression of vitamin D receptors in dopamine neurons in the brain, especially in the substantia nigra area increased the expression of tyrosine hydroxylase which is a rate-limiting enzyme in dopamine synthesis in adrenal medulla cells with the effect of 1.25 (OH) D2, D3 [21] . In addition, both vitamin D receptors and 1 alpha-hydroxylase enzyme are expressed in human brain, especially in substantia nigra neurons (probably dopaminergic) [22] . In animal experiments, it has been showed that 1.25 dihydroxy vitamin D which is the active metabolite of vitamin D could partly protect neurons against ischemic brain damage and the damages caused by 6-hydroxydopamine (a substance used to create Parkinson) [23] [24] . In a study conducted by Balaban et Iron deficiency is related to RLS. It plays an important role in secondary reasons such as pregnancy and anemia. Iron is required as a cofactor for tyrosine hydroxylase, which is the ratelimiting enzyme for the formation of dopamine from levodopa. Therefore, dopamine synthesis may decrease in case of iron deficiency. A significant improvement is observed in some cases of RLS through iron treatment. In addition, iron concentration is also found to be low in substantia nigra in RLS patients [26] [27] . In all groups where iron deficiency incidence is high, and in cases of pregnancy, end-stage renal failure and anemia, RLS incidence was 20-30% [27] . However, 75% of individuals with RLS are known to have decreasing iron stores [28] . In a study conducted on 79 patients with iron deficiency, 58% of patients had 25 (OH) vitamin D levels of < 30 ng/ml whereas 39% had levels of < 20 ng/ml [29] . In a study conducted by Balaban et al., ferritin levels between the groups with and without RLS were also found different, and ferritin levels were found lower in the women patients with RLS [25] . In a study conducted by Zbroch et al., dialysis (75 hemodialyses and 26 peritoneal dialyzes) patients were included in the study and dopamine levels of patients were low [30] . In this study, no significant relation was determined between anemia and RLS. Consequently, vitamin D levels were significantly lower in hemodialysis patients with RLS. 
